Clinical Trial Update: Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating hyperpolarized 13C pyruvate MRI to assess treatment response in pancreatic ductal adenocarcinoma; status terminated with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Zhen Wang, MD | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2023-11-13